EMERGENCY:Sudden complete loss of movement (akinetic crisis) —call040-46324365immediately — 24 hours, 7 days— 24/7
Including MRgFUS and Deep Brain Stimulation at KIMS Neuroscience — the only centre in Telangana and AP offering both advanced treatments.
Movement Disorders
Neurology & Neurosurgery
MRgFUS · DBS · Levodopa
| Fact | Details |
|---|---|
| Category | Neurodegenerative · Movement Disorder |
| Second most common | Worldwide, after Alzheimer's Disease (8.5 million+ people globally per WHO) |
| Primary cause | Dopamine cell loss in the substantia nigra; alpha-synuclein (Lewy body) accumulation |
| First-line treatment | Levodopa-Carbidopa, optimised by a movement disorder specialist |
| Advanced options at KIMS | Deep Brain Stimulation (DBS) and MRI-guided Focused Ultrasound (MRgFUS) |
| Hereditary in | Only 10–15% of cases — most are sporadic |
Parkinson's Disease is a condition in which the brain gradually loses its ability to produce dopamine — the chemical messenger your brain uses to coordinate smooth, controlled movement. When dopamine levels fall low enough, movement becomes slower, stiffer, and harder to control, producing the tremors, rigidity, and slowness most people associate with Parkinson's.
Parkinson's is the second most common neurodegenerative condition in the world, after Alzheimer's Disease. The World Health Organization estimates that over 8.5 million people are living with it globally. In India, the true number is likely far higher than official figures suggest, because many cases — particularly in rural areas — go undiagnosed for years.
With the right treatment — and in Hyderabad today, that includes some of the most advanced treatments in the world — most people with Parkinson's live for many years with a good quality of life. At KIMS Neuroscience, Secunderabad, the team has run the region's Parkinson's programme for over two decades. KIMS Neuroscience pioneered both Deep Brain Stimulation (DBS) and MRgFUS in this region — the two most advanced surgical treatments. KIMS is the only centre in Telangana and Andhra Pradesh offering both treatments.
Book a Consultation
Speak directly with our specialist team. No referral required. Monday to Saturday.
040-44885000International enquiries: info@kimsneurosciences.comParkinson's symptoms fall into two groups: movement symptoms (which most people know about) and non-movement symptoms (which often appear years before motor problems start and are still frequently overlooked).
A rhythmic shaking, most commonly in one hand or fingers, that happens when the hand is relaxed and still. Typically reduces when reaching for something — usually the first symptom families notice.
Everything takes longer. Walking slows, arms don't swing, facial expressions become less animated, and tasks like buttoning a shirt or getting out of a chair become a real effort.
Muscles feel tight or stiff. Arms and legs feel heavy and difficult to move freely. Many people describe aching shoulders as an early symptom before diagnosis.
In later stages, balance is affected and falls become a risk. This is typically not an early symptom.
A sudden episode where the feet feel stuck to the floor and the person cannot take the next step. Happens most often in doorways, when turning, or in crowded spaces.
One of the most consistent early signs of Parkinson's. Persistent loss of smell without an obvious cause warrants neurological evaluation.
Physically moving, talking, shouting, or striking out during sleep. A known early sign of Parkinson's in many patients.
Chronic, unexplained constipation is more common in people who will later develop Parkinson's than in the general population.
These are not just reactions to having Parkinson's — they are symptoms of the disease itself, caused by the same dopamine changes affecting mood.
The voice gradually becomes quieter and less varied in tone.
Letters gradually become smaller and more cramped — a subtle but important early indicator.
The direct cause of Parkinson's is the loss of dopamine-producing cells in the substantia nigra. What causes those cells to die? Research has identified several contributing factors:
Alpha-synuclein protein folds into the wrong shape and clumps inside brain cells, forming Lewy bodies. These clumps damage and eventually kill the cells they accumulate in.
About 10–15% of cases are linked to an inherited gene change — most commonly LRRK2, SNCA, PINK1, or PRKN. A family history modestly increases risk, but most relatives do not develop Parkinson's.
Long-term exposure to certain pesticides and herbicides has been associated with higher risk. Significant head injuries have also been linked.
The single biggest risk factor. Parkinson's affects approximately 1 in 100 people over 60, with risk rising each decade. Young-onset Parkinson's (before 50) does occur and is more likely to have a genetic cause.
There is no single blood test or brain scan that definitively diagnoses Parkinson's. The diagnosis is made by a specialist following the Movement Disorder Society criteria — a careful examination of symptoms and a series of targeted tests.
The specialist explores when symptoms first appeared, which side was affected first, how symptoms have progressed, and any non-movement symptoms or family history.
Assessment of tremor quality and pattern, movement speed, limb rigidity, facial expression, walking pattern, and balance reflexes.
A dose of levodopa is given and movement is assessed over subsequent hours. A meaningful improvement strongly indicates Parkinson's Disease.
Rules out other causes of similar symptoms — brain tumour, stroke, or normal pressure hydrocephalus.
A specialised nuclear medicine scan showing the dopamine system's function. Confirms the diagnosis and distinguishes Parkinson's from Essential Tremor.
Baseline cognitive testing to track changes over time and guide treatment decisions, including suitability for Deep Brain Stimulation.
A simple, quick, inexpensive assessment that supports the clinical picture.
Parkinson's cannot currently be cured — but it is one of the most treatable neurological conditions we see. With the right combination of medication, physical therapy, and advanced surgical treatment, most people maintain a good quality of life for many years.
The most effective medication for Parkinson's. Replaces the dopamine the brain is no longer producing. Supplemented by dopamine agonists, MAO-B inhibitors, COMT inhibitors, and amantadine as the disease evolves.
A thin electrode placed in a specific brain target is connected to a pacemaker-like device. The continuous electrical signal smooths motor fluctuations and restores consistent movement control. KIMS Neuroscience performs DBS at KIMS.
Focused sound waves guided by live MRI permanently disrupt the tremor circuit — no incision, no general anaesthetic, no implant. Most patients go home the same day. KIMS is the only centre in Telangana and AP offering this.
Specialist physiotherapy programme proven to slow functional decline in Parkinson's. Should begin at diagnosis, not when things get difficult.
Addresses the quiet, monotone voice that develops in many Parkinson's patients. Early referral gives the best results.
See a specialist at KIMS Neuroscience if you or a family member notices any of the following. The earlier Parkinson's is diagnosed, the earlier the right treatment starts — and the better the outcomes. You do not need a referral to book an assessment.
A tremor in one hand or arm — particularly when the hand is at rest
Significant slowing down of movement compared to a year or two ago
Stiffness or unexplained aching, particularly in one shoulder or arm
Changes in walking — a shuffle, reduced arm swing, or smaller steps
Handwriting that has become noticeably smaller and more cramped
A loss of the sense of smell that has persisted for months with no obvious cause
Physically acting out dreams during sleep
A voice that has become softer or harder to hear
The honest picture of Parkinson's Disease is this: it is progressive, but its pace varies enormously between individuals. Some progress slowly over many years; others more quickly. The right treatment makes a real difference to that trajectory.
The early years — particularly with well-managed medication — are often manageable. Most people continue working, driving, and living independently. Motor complications typically develop after several years of levodopa, and this is when the treatment plan needs to evolve — often towards DBS or other interventions.
Patients who would previously have been largely disabled by tremors are walking out of KIMS Neuroscience the day after MRgFUS. Patients who could barely get out of a chair during OFF periods are living independently years after DBS. Parkinson's is not what it used to be — and the team at KIMS, Hyderabad is part of the reason why.
Related Conditions
Parkinson's belongs to a broader family of neurodegenerative movement disorders:
Concerned about Parkinson's symptoms?
Speak to the KIMS Neuroscience Movement Disorders team today. No referral required.
International enquiries: info@kimsneurosciences.com